Fellowship in General Infectious Diseases
The Fellowship in General Infectious Diseases is a comprehensive 52-week advanced training program designed to provide healthcare professionals with in-depth knowledge and practical expertise in the prevention, diagnosis, treatment, and management of infectious diseases affecting diverse patient populations. As infectious …
The Fellowship in General Infectious Diseases is a comprehensive 52-week advanced training program designed to provide healthcare professionals with in-depth knowledge and practical expertise in the prevention, diagnosis, treatment, and management of infectious diseases affecting diverse patient populations. As infectious diseases continue to represent a major global health challenge, healthcare providers require specialized skills to address emerging pathogens, antimicrobial resistance, healthcare-associated infections, and complex infectious conditions across clinical settings.
This fellowship offers a structured and evidence-based curriculum that integrates the fundamental principles of infectious disease medicine with contemporary clinical practices. Participants gain a thorough understanding of microbiology, immunology, epidemiology, infection control, antimicrobial stewardship, and public health strategies. The program emphasizes the identification and management of bacterial, viral, fungal, and parasitic infections while exploring the mechanisms of disease transmission, host-pathogen interactions, and infection prevention strategies.
Throughout the course, learners develop proficiency in evaluating patients presenting with infectious diseases, interpreting laboratory and microbiological investigations, selecting appropriate antimicrobial therapies, and managing complicated infections in both inpatient and outpatient environments. Special focus is given to respiratory infections, gastrointestinal infections, urinary tract infections, skin and soft tissue infections, bloodstream infections, central nervous system infections, and infections affecting immunocompromised individuals.
The fellowship also explores contemporary challenges in infectious disease practice, including emerging and re-emerging infections, antimicrobial resistance, outbreak preparedness, travel-related infections, zoonotic diseases, tropical infections, and global health concerns. Participants learn how to implement infection prevention measures, develop antimicrobial stewardship programs, and contribute to healthcare quality improvement initiatives aimed at reducing infection-related morbidity and mortality.
In addition to clinical management, the program provides extensive training in epidemiology, disease surveillance, outbreak investigation, vaccination strategies, and public health interventions. Learners gain insights into the role of infectious disease specialists in multidisciplinary healthcare teams and understand how evidence-based guidelines influence patient care and healthcare policy.
The curriculum combines theoretical learning with case-based discussions, clinical scenarios, research-oriented activities, and practical applications that reflect real-world infectious disease challenges. By analyzing complex cases and current clinical guidelines, participants strengthen their clinical reasoning, diagnostic accuracy, and decision-making skills.
Upon successful completion of the Fellowship in General Infectious Diseases, graduates will be equipped to confidently diagnose, treat, prevent, and manage a broad spectrum of infectious diseases while promoting patient safety, antimicrobial stewardship, and public health. The program is ideal for medical graduates, physicians, internists, family medicine practitioners, emergency medicine professionals, public health practitioners, and other healthcare providers seeking specialized expertise in infectious disease management.
This fellowship serves as a valuable credential for professionals aiming to enhance their clinical competence, advance their careers, contribute to infection prevention initiatives, and play a vital role in addressing current and future infectious disease challenges in healthcare systems worldwide.
- 7 Sections
- 98 Lessons
- 52 Weeks
- CNS Infection— Infectious Diseases16
- 1.1BacterialMeningitis: Definition
- 1.2BacterialMeningitis: Signs/Symptomsin Newborns & Younger Children
- 1.3Neisseria Meningitidis(Meningococcus): Signs & Symptoms
- 1.4Bacterial Meningitis: Diagnosis & CSF Findings
- 1.5BacterialMeningitis:Management & Empirical Treatment When Gram’s Stain (−)
- 1.6BacterialMeningitis: Etiology &MCV-4 Meningococcal Vaccine
- 1.7Encephalitis: Definition and Etiology
- 1.8Encephalitis: Vector-borne Viruses
- 1.9Encephalitis: Signs & Symptoms
- 1.10Encephalitis: Diagnosis
- 1.11Encephalitis: Supportive Management
- 1.12Brain Abscess: Etiology
- 1.13Brain Abscess: Pathology
- 1.14Brain Abscess: Signs & Symptoms
- 1.15Brain Abscess: Diagnosis
- 1.16Brain Abscess: InitialManagement
- Cardiovascular Infections15
- 2.1Infective Endocarditis(IE): Definition and Epidemiology
- 2.2Infective Endocarditis(IE): Pathology
- 2.3Infective Endocarditis(IE): Etiology
- 2.4Infective Endocarditis(IE): Classification
- 2.5Infective Endocarditis(IE): Signs and Symptoms
- 2.6Endocarditis:Microbiologic Dx
- 2.7Infective Endocarditis(IE):Management
- 2.8IEManagement : Antibiotic Treatment
- 2.9IEManagement: Other Procedures Requiring Antibiotic Prophylaxis
- 2.10IE Prognosis: Areas of Uncertainty
- 2.11Pericarditis: Epidemiology
- 2.12Pericarditis: Signs and Symptoms
- 2.13Pericarditis: Diagnosis
- 2.14Myocarditis: Definition and Epidemiology
- 2.15Myocarditis: Signs, Diagnosis & Management
- Upper Respiratory Infections17
- 3.1Acute Pharyngitis: Definition and Epidemiology
- 3.2Group A Streptococcus(GAS): Signs and Symptoms
- 3.3Group A Streptococcus(GAS): Diagnosis and Treatment
- 3.4Acute Sinusitis: Definition and Pathology
- 3.5Acute Sinusitis: Microbiology and Epidemiology
- 3.6Acute Sinusitis: Management
- 3.7Acute OtitisMedia (Middle EarInfection): Definition and Epidemiology
- 3.8Acute OtitisMedia (Middle EarInfection): Etiology
- 3.9Acute OtitisMedia (Middle EarInfection): Signs and Symptoms
- 3.10Acute OtitisMedia (Middle EarInfection): Management
- 3.11Acute OtitisMedia (Middle EarInfection): Etiology and Prognosis
- 3.12Influenza A: Definition and Etiology
- 3.13Influenza A: Pathology
- 3.14Influenza A: Epidemiology
- 3.15Influenza A: Signs, Symptoms & Transmission
- 3.16Influenza A and B:Management
- 3.17Influenza: Management and Prevention
- Gastrointestinal Infections15
- 4.1Infectious Diarrhea and Food Poisoning: Definition & Epidemiology
- 4.2Infectious Diarrhea: Diagnosis
- 4.3Watery Diarrhea: Vibrio cholerae / Cholera Toxin
- 4.4Watery Diarrhea: E. coli et al.
- 4.5Clostridioides difficile Infection (Antibiotics)
- 4.6Acute Dysentery
- 4.7Enteric Fever(Typhoid Fever): Etiology
- 4.8Hemolytic-Uremic Syndrome (HUS): Signs and Symptoms
- 4.9Acute Bacterial Diarrhea:Food–Bacteria Associations
- 4.10Hepatitis: Definition and Epidemiology
- 4.11Hepatitis: Etiology
- 4.12Hepatitis: Pathology
- 4.13Hepatitis: Signs and Symptoms
- 4.14Hepatitis: Diagnosis and Management
- 4.15Hepatitis: Prevention
- Genital and Sexually Transmitted Infections23
- 5.1Genital and Sexually Transmitted Infections
- 5.2Gonorrhea: Signs, Symptoms & Diagnosis
- 5.3Gonorrhea and Chlamydia trachomatis: Management
- 5.4Pelvic Inflammatory Disease (PID): Definition and Pathology
- 5.5Pelvic Inflammatory Disease (PID): Signs and Symptoms
- 5.6Pelvic Inflammatory Disease (PID): Management and Etiology
- 5.7Syphilis: Definition and Pathology
- 5.8Primary and Secondary Syphilis
- 5.9Latent Syphilis, Tertiary Syphilis, Syphilitic Meningitis &Meningovascular Syphilis
- 5.10Parenchymatous Syphilis and Tabes Dorsalis(SyphiliticMyelopathy)
- 5.11Cardiovascular Syphilis and Late Benign (Gummatous) Syphilis
- 5.12Syphilis: Diagnosis
- 5.13Syphilis: Therapy
- 5.14Chancroid: Definition and Pathology
- 5.15Chancroid: Signs and Symptoms
- 5.16Chancroid: Diagnosis and Therapy
- 5.17Lymphogranuloma Venereum(LGV): Definition
- 5.18Lymphogranuloma Venereum(LGV): Signs/Symptoms, Diagnosis &Management
- 5.19Donovanosis(Granuloma Inguinale)
- 5.20Genital Herpes: Definition and Epidemiology
- 5.21Genital Herpes: Signs, Symptoms & Diagnosis
- 5.22Genital Herpes:Management and Etiology
- 5.23Human Immunodeficiency Virus(HIV): Definition and Pathology
- Genital and Sexually Transmitted Infections6
- 6.1Human Immunodeficiency Virus(HIV): Signs, Symptoms & Opportunistic Infections
- 6.2Human Immunodeficiency Virus(HIV): Diagnosis and Management
- 6.3Human Immunodeficiency Virus(HIV): Prevention and Prognosis
- 6.4Genital Warts(Condyloma Acuminatum): Definition, Epidemiology & Etiology
- 6.5Genital Warts(Condyloma Acuminatum): Pathology, Signs & Symptoms
- 6.6Genital Warts(Condyloma Acuminatum): Diagnosis and Management
- Urinary Tract Infections6
- 7.1Cystitis: Definition, Epidemiology & Etiology
- 7.2Cystitis: Pathology, Signs & Symptoms
- 7.3Cystitis: Diagnosis and Management
- 7.4Pyelonephritis(KidneyInfection) and Perinephric Abscess: Definition, Epidemiology & Etiology
- 7.5Pyelonephritis(KidneyInfection) and Perinephric Abscess: Pathology, Signs & Symptoms
- 7.6Pyelonephritis(KidneyInfection) and Perinephric Abscess: Diagnosis & Management
You might be intersted in
-
89 Students
-
52 Weeks
-
87 Students
-
52 Weeks
-
67 Students
-
52 Weeks
-
56 Students
-
52 Weeks